Institute for Clinical and Economic Review Releases Draft Evidence Report on Ulcerative Colitis Therapies
May 27, 2020
May 27, 2020
BOSTON, Massachusetts, May 27 -- The Institute for Clinical and Economic Review issued the following announcement:
The Institute for Clinical and Economic Review (ICER) released a Draft Evidence Report assessing the comparative clinical effectiveness and value of treatments for ulcerative colitis (UC). This preliminary draft marks the midpoint of ICER's process of assessing these treatments, and the findings within this document should not be interpreted to be ICER's final . . .
The Institute for Clinical and Economic Review (ICER) released a Draft Evidence Report assessing the comparative clinical effectiveness and value of treatments for ulcerative colitis (UC). This preliminary draft marks the midpoint of ICER's process of assessing these treatments, and the findings within this document should not be interpreted to be ICER's final . . .